Literature DB >> 21452883

Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery.

Mi-Hee Kim1, Hee-Kyung Na, Young-Kwan Kim, Soo-Ryoon Ryoo, Hae Sung Cho, Kyung Eun Lee, Hyesung Jeon, Ryong Ryoo, Dal-Hee Min.   

Abstract

Among various nanoparticles, the silica nanoparticle (SiNP) is an attractive candidate as a gene delivery carrier due to advantages such as availability in porous forms for encapsulation of drugs and genes, large surface area to load biomacromolecules, biocompatibility, storage stability, and easy preparation in large quantity with low cost. Here, we report on a facile synthesis of monodispersed mesoporous silica nanoparticles (MMSN) possessing very large pores (>15 nm) and application of the nanoparticles to plasmid DNA delivery to human cells. The aminated MMSN with large pores provided a higher loading capacity for plasmids than those with small pores (∼2 nm), and the complex of MMSN with plasmid DNA readily entered into cells without supplementary polymers such as cationic dendrimers. Furthermore, MMSN with large pores could efficiently protect plasmids from nuclease-mediated degradation and showed much higher transfection efficiency of the plasmids encoding luciferase and green fluorescent protein (pLuc, pGFP) compared to MMSN with small pores (∼2 nm).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21452883     DOI: 10.1021/nn103130q

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  44 in total

1.  Biomineralization Precursor Carrier System Based on Carboxyl-Functionalized Large Pore Mesoporous Silica Nanoparticles.

Authors:  Sheng Wei; Hua Wu; Xiao-Juan Luo
Journal:  Curr Med Sci       Date:  2020-03-13

Review 2.  Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.

Authors:  Chengyi Tu; Subhamoy Das; Aaron B Baker; Janeta Zoldan; Laura J Suggs
Journal:  ACS Nano       Date:  2015-04-10       Impact factor: 15.881

Review 3.  Theragnostic potentials of core/shell mesoporous silica nanostructures.

Authors:  Aswathy Ravindran Girija; Sivakumar Balasubramanian
Journal:  Nanotheranostics       Date:  2019-01-01

Review 4.  Composite nanoparticles for gene delivery.

Authors:  Yuhua Wang; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

5.  Advanced Functional Nanomaterials for Theranostics.

Authors:  Haoyuan Huang; Jonathan F Lovell
Journal:  Adv Funct Mater       Date:  2016-11-07       Impact factor: 18.808

6.  In vivo toxicity of orally administrated silicon dioxide nanoparticles in healthy adult mice.

Authors:  Ramin Hassankhani; Mohammad Esmaeillou; Ali Asghar Tehrani; Keyvan Nasirzadeh; Fatemeh Khadir; Hamid Maadi
Journal:  Environ Sci Pollut Res Int       Date:  2014-08-13       Impact factor: 4.223

Review 7.  Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.

Authors:  Nicholas H Farina; Areg Zingiryan; Michael A Vrolijk; Scott D Perrapato; Steven Ades; Gary S Stein; Jane B Lian; Christopher C Landry
Journal:  J Cell Physiol       Date:  2018-04-16       Impact factor: 6.384

8.  Nanofibrous Spongy Microspheres To Distinctly Release miRNA and Growth Factors To Enrich Regulatory T Cells and Rescue Periodontal Bone Loss.

Authors:  Zhongning Liu; Xin Chen; Zhanpeng Zhang; Xiaojin Zhang; Laura Saunders; Yongsheng Zhou; Peter X Ma
Journal:  ACS Nano       Date:  2018-08-29       Impact factor: 15.881

Review 9.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

10.  Size-selective pH-operated megagates on mesoporous silica materials.

Authors:  Min Xue; Dennis Cao; J Fraser Stoddart; Jeffrey I Zink
Journal:  Nanoscale       Date:  2012-12-07       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.